The Acellular Fraction of Stored Platelets Promotes Tumor Cell Invasion

Journal of Surgical Research

Volumn 153, Issue 1, 2009, Pages 132-137

  Dineen, Sean P ^a   Roland, Christina L ^a   Toombs, Jason E ^a   Kelher, Marguerite ^b   Silliman, Christopher C ^b   Brekken, Rolf A ^a   Barnett Jr , Carlton C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

breast cancer; pancreatic cancer; platelet; VEGF

Indexed keywords

BEVACIZUMAB; CYTOKINE; GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL FRACTIONATION; CELL INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PLASMA; PRIORITY JOURNAL; THROMBOCYTE PRESERVATION; TUMOR CELL;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BLOOD PLATELETS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PLATELET TRANSFUSION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 63649107424     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.04.013     Document Type: Article

References (28)

1. Adamson J.W. New blood, old blood, or no blood?. New Engl J Med 358 (2008) 1295
2. Silliman C.C., Bjornsen A.J., Wyman T.H., et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 43 (2003) 633
3. Vamvakas E.C., and Blajchman M.A. Transfusion-related immunomodulation (TRIM): An update. Blood Rev 21 (2007) 327
4. Silliman C.C., Voelkel N.F., Allard J.D., et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 101 (1998) 1458
5. Yeh J.J., Gonen M., Tomlinson J.S., et al. Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumour of the pancreas. Br J Surg 94 (2007) 466
6. Weitz J., D'Angelica M., Gonen M., et al. Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer. J Clin Oncol 21 (2003) 4597
7. Park S.J., Kim S.W., Jang J.Y., et al. Intraoperative transfusion: Is it a real prognostic factor of periampullary cancer following pancreatoduodenectomy?. World J Surg 26 (2002) 487
8. Blumberg N., Heal J.M., and Rowe J.M. A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]. BMC Blood Disord 4 (2004) 6
9. Technical Manual (2005), AAAB, Bethesda, MD
10. AuBuchon J.P., Herschel L., and Roger J. Further evaluation of a new standard of efficacy for stored platelets. Transfusion 45 (2005) 1143
11. AuBuchon J.P., Taylor H., Holme S., et al. In vitro and in vivo evaluation of leukoreduced platelets stored for 7 days in CLX containers. Transfusion 45 (2005) 1356
12. Fang C.T., Chambers L.A., Kennedy J., et al. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Transfusion 45 (2005) 1845
13. Anitua E., Andia I., Ardanza B., et al. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91 (2004) 4
14. Zimmermann R., Jakubietz R., Jakubietz M., et al. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion 41 (2001) 1217
15. Alvarez R.H., Kantarjian H.M., and Cortes J.E. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc 81 (2006) 1241
16. Carlson N.E., and Roach Jr. R.B. Platelet-rich plasma: Clinical applications in dentistry. J Am Dental Assoc (1939) 133 (2002) 1383
17. Ranieri G., Coviello M., Patruno R., et al. Vascular endothelial growth factor concentrations in the plasma-activated platelets rich (P-APR) of healthy controls and colorectal cancer patients. Oncol Rep 12 (2004) 817
18. Sledge Jr. G.W. Vascular endothelial growth factor in breast cancer: Biologic and therapeutic aspects. Semin Oncol 29 (2002) 104
19. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. New Engl J Med 350 (2004) 2335
20. Mohr R., Goor D.A., Yellin A., et al. Fresh blood units contain large potent platelets that improve hemostasis after open heart operations. Ann Thorac Surg 53 (1992) 650
21. Kut C., Mac Gabhann F., and Popel A.S. Where is VEGF in the body?. A meta-analysis of VEGF distribution in cancer. Br J Cancer 97 (2007) 978
22. Gupta G.P., and Massague J. Platelets and metastasis revisited: A novel fatty link. J Clin Invest 114 (2004) 1691
23. Nash G.F., Turner L.F., Scully M.F., et al. Platelets and cancer. Lancet Oncol 3 (2002) 425
24. Nieswandt B., Hafner M., Echtenacher B., et al. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59 (1999) 1295
25. Korpanty G., Carbon J.G., Grayburn P.A., et al. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res 13 (2007) 323
26. Beck A.W., Luster T.A., Miller A.F., et al. Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice. Int J Cancer 118 (2006) 2639
27. Folkman J. Angiogenesis: An organizing principle for drug discovery?. Nat Rev 6 (2007) 273
28. Koch C.G., Li L., Sessler D.I., et al. Duration of red-cell storage and complications after cardiac surgery. New Engl J Med 358 (2008) 1229